Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: study protocol of a randomized controlled trial
暂无分享,去创建一个
Q. Sun | S. Shen | Yidong Zhou | F. Mao | Yan Lin | J. Guan | Xin Huang | Xiaohui Zhang | R. Yao | Changjun Wang | Hanjiang Zhu | Chang Chen | Jia-lin Zhao